Interest Expense in USD of Verona Pharma plc from 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Verona Pharma plc quarterly/annual Interest Expense history and change rate from 2019 to Q3 2024.
  • Verona Pharma plc Interest Expense for the quarter ending 30 Sep 2024 was $9.88M, a 2364% increase year-over-year.
  • Verona Pharma plc Interest Expense for the twelve months ending 30 Sep 2024 was $13.8M, a 732% increase year-over-year.
  • Verona Pharma plc annual Interest Expense for 2023 was $2.06M, a 295% increase from 2022.
  • Verona Pharma plc annual Interest Expense for 2022 was $521K, a 53.2% increase from 2021.
  • Verona Pharma plc annual Interest Expense for 2021 was $340K, a 871% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Verona Pharma plc Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $13.8M $9.88M +$9.48M +2364% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2024
Q2 2024 $4.37M $1.76M +$1.02M +137% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $3.35M $1.59M +$1.29M +441% 01 Jan 2024 31 Mar 2024 10-Q 10 May 2024
Q4 2023 $2.06M $623K +$393K +171% 01 Oct 2023 31 Dec 2023 10-K 29 Feb 2024
Q3 2023 $1.66M $401K +$285K +246% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024
Q2 2023 $1.38M $740K +$649K +713% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $730K $293K +$209K +249% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 $521K $230K +$145K +171% 01 Oct 2022 31 Dec 2022 10-K 29 Feb 2024
Q3 2022 $376K $116K +$30K +34.9% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023
Q2 2022 $346K $91K +$6K +7.06% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 $340K $84K $0 0% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 $340K $85K +$50K +143% 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2023
Q3 2021 $290K $86K +$86K 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $204K $85K +$85K 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $119K $84K +$84K 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022
Q4 2020 $35K $35K 01 Oct 2020 31 Dec 2020 10-K 03 Mar 2022
Q3 2020 $0 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 $0 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 $0 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021

Verona Pharma plc Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.06M +$1.54M +295% 01 Jan 2023 31 Dec 2023 10-K 29 Feb 2024
2022 $521K +$181K +53.2% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024
2021 $340K +$305K +871% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2023
2020 $35K +$35K 01 Jan 2020 31 Dec 2020 10-K 03 Mar 2022
2019 $0 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.